Immunopharmacotherapy for Opioid-Use Disorder: Applicability to Practice is organized by echelon.
This course is accessible until 12/31/2024.
Description:
This course is designed to increase your awareness and evidence-based knowledge regarding immunopharmacotherapy treatment for opioid-use disorder, and its impact on patient care. Opioid-use disorder, its current state and treatments, immunopharmacotherapy, its mechanism of action with possible drug-interactions, and the provider’s vital role in utilizing this knowledge to develop adequate pain management and appropriate anesthetic plans to future patients treated with the anti-opioid vaccinations should the drugs
receive approval will be discussed.
By completing this course, the healthcare professional will gain an increased knowledge regarding research on pre-clinical immunopharmacotherapy for the treatment of opioid-use disorder. An alertness toward a potential future encounter with the vaccinations will prepare providers to administer safe, effective patient care and follow-up.
Outcomes:
Upon completion of this course, program participants will be able to:
• Identify the signs and symptoms of opioid-use disorder.
• Distinguish between current opioid-use disorder treatments and their side-effects.
• Define immunopharmacotherapy.
• Identify the mechanism of action of immunopharmacotherapy.
• Understand the pharmacodynamics of anti-opioid vaccinations in pre-clinical animal subjects.
• Distinguish the potential physiological side-effects and impact from treatment with immunopharmacotherapy on opioid analgesics.
• Incorporate appropriate pain management techniques within an anesthetic plan for surgical patients undergoing immunopharmacotherapy for the treatment of an opioid-use disorder.
• Identify the provider’s role in opioid-use disorder and immunopharmacotherapy.
Additional Details Will Be Posted as Soon as Information is Available.